Abstract:Nano-based drug delivery system (NDDS) for photodynamic therapy (PDT) has emerged as an innovative strategy for enhanced anticancer treatment, however, the limited penetration depth of nanocarrier and poor therapeutic efficacy of PDT against hypoxic or necrotic cells might cause unsatisfactory outcomes such as tumor recurrence. Thus, developing a therapeutic modality that is highly penetrable and has synergistic effects with PDT in wiping out hypoxic tumorous cells is an unmet need. Herein, the hybrid Cy7-NO2/HPC/TPZ NPs were prepared by doping photosensitizer-hypericin (HPC), hypoxic activated chemotherapeutic prodrug-tirapazamine (TPZ), and hypoxic detection NIR probe Cy7-NO2. Aside from acting as the photosensitizer, the nanoparticles inherited the necrotic targeting ability from HPC, which allowed them to accumulate precisely at tumors with satisfactory penetration depth. Then, owing to the increasing tumor necrosis during the treatment, the ensuing positive feedback loop between necrotic degree and elevated tumor accumulation would occur. Besides, the contradictory demand of oxygen supported the enhanced anticancer efficacy by realizing chemo-co-photodynamic therapy with synergistic combination of HPC and TPZ. Due to the hypoxic heterogenicity in solid tumors, therapeutical outcomes of PDT and TPZ varied significantly under different circumstances. Thus, the Cy7-NO2 probe in NPs was applied to detect real-time hypoxic degree in advance for operators to adjust the optimal ratio of TPZ to HPC for different therapeutic scenarios and finally realized a specific and personalized dosing strategy. In summary, this synergistic chemophotodynamic nanomedicine proposed an innovative site-specific targeting strategy for improved tumor penetration via constructing a positive feedback loop between necrosis degree and tumor accumulation, as well as providing an option for imaging-guiding personalized theranostic strategy.

Hypoxia-responsive Near Infrared Thioxanthene-Hemicyanine Nanoparticle for Multimodal Imaging-Guided Photothermal/photodynamic Therapy

Multifunctionalized Tumor-Triggered Targeting Theranostic Nanoparticles as a Precision NIR Imaging-Guided Nanoplatform for Photothermal/Photodynamic Therapy

Hypoxia-triggered single molecule probe for high-contrast NIR II/PA tumor imaging and robust photothermal therapy

An Activatable Near-Infrared Chromophore for Multispectral Optoacoustic Imaging of Tumor Hypoxia and for Tumor Inhibition

Macromolecular Conjugated Cyanine Fluorophore Nanoparticles for Tumor-Responsive Photo Nanotheranostics

Iodinated Cyanine Dye-Based Nanosystem for Synergistic Phototherapy and Hypoxia-Activated Bioreductive Therapy.

A Tumor-Targeting Near-Infrared Heptamethine Cyanine Photosensitizer with Twisted Molecular Structure for Enhanced Imaging-Guided Cancer Phototherapy

An Activatable Phototheranostic Probe for Anti‐hypoxic Type I Photodynamic‐ and Immuno‐Therapy of Cancer

Activatable Near Infrared Dye Conjugated Hyaluronic Acid Based Nanoparticles As a Targeted Theranostic Agent for Enhanced Fluorescence/ct/photoacoustic Imaging Guided Photothermal Therapy

Dual-mode imaging guided multifunctional theranosomes with mitochondria targeting for photothermally controlled and enhanced photodynamic therapy in vitro and in vivo.

Protein-based photothermal theranostics for imaging-guided cancer therapy

NIR and Reduction Dual-Sensitive Polymeric Prodrug Nanoparticles for Bioimaging and Combined Chemo-Phototherapy

Theranostic Colloidal Nanoparticles of Pyrrolopyrrole Cyanine Derivatives for Simultaneous Near-Infrared Fluorescence Cancer Imaging and Photothermal Therapy

BODIPY-Based Multifunctional Nanoparticles for Dual Mode Imaging-Guided Tumor Photothermal and Photodynamic Therapy.

pH-Sensitive self-assembling nanoparticles for tumor near-infrared fluorescence imaging and chemo-photodynamic combination therapy.

Tumor‐Targeting Near‐Infrared Dimeric Heptamethine Cyanine Photosensitizers with an Aromatic Diphenol Linker for Imaging‐Guided Cancer Phototherapy

An Activatable Phototheranostic Nanoplatform for Tumor Specific NIR-II Fluorescence Imaging and Synergistic NIR-II Photothermal-Chemodynamic Therapy.

A Photothermal-Hypoxia Sequentially Activatable Phase-Change Nanoagent for Mitochondria-Targeting Tumor Synergistic Therapy

NIR-Light-Intensified Hypoxic Microenvironment for Cascaded Supra-Prodrug Activation and Synergistic Chemo/Photodynamic Cancer Therapy

A Self-Amplified Necrotic Targeting Theranostic Nanoparticle with Deep Tumor Penetration for Imaging-Guided Personalized Chemo-Photodynamic Therapy

Near-infrared photoactivatable three-in-one nanoagents to aggravate hypoxia and enable amplified photo-chemotherapy